318 related articles for article (PubMed ID: 33434318)
1. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults.
Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR
Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
[TBL] [Abstract][Full Text] [Related]
3. Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).
Parrinello CM; Rudolph BJ; Lazo M; Gallo LC; Thyagarajan B; Cotler SJ; Qi Q; Seeherunvong T; Vidot DC; Strickler HD; Kaplan RC; Isasi CR
J Clin Gastroenterol; 2019 Feb; 53(2):e46-e53. PubMed ID: 29099463
[TBL] [Abstract][Full Text] [Related]
4. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
[TBL] [Abstract][Full Text] [Related]
5. Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
Schneider AL; Lazo M; Ndumele CE; Pankow JS; Coresh J; Clark JM; Selvin E
Diabet Med; 2013 Aug; 30(8):926-33. PubMed ID: 23510198
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
7. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
8. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
Lazo M; Rubin J; Clark JM; Coresh J; Schneider AL; Ndumele C; Hoogeveen RC; Ballantyne CM; Selvin E
J Hepatol; 2015 Apr; 62(4):841-7. PubMed ID: 25433159
[TBL] [Abstract][Full Text] [Related]
9. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
[TBL] [Abstract][Full Text] [Related]
10. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults.
Tsai J; Ford ES; Li C; Zhao G
Addict Behav; 2012 Jan; 37(1):78-84. PubMed ID: 21975024
[TBL] [Abstract][Full Text] [Related]
11. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
[TBL] [Abstract][Full Text] [Related]
13. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.
Chen SC; Tsai SP; Jhao JY; Jiang WK; Tsao CK; Chang LY
Sci Rep; 2017 Jul; 7(1):4649. PubMed ID: 28680048
[TBL] [Abstract][Full Text] [Related]
14. Liver Enzymes, Fatty Liver and Type 2 Diabetes Mellitus in a Jinchang Cohort: A Prospective Study in Adults.
Zhang J; Cheng N; Ma Y; Li H; Cheng Z; Yang Y; He C; Li J; Pu H; Shen X; Ren X; Shi D; Pu R; Gan T; Ding J; Zheng T; Bai Y
Can J Diabetes; 2018 Dec; 42(6):652-658. PubMed ID: 29936075
[TBL] [Abstract][Full Text] [Related]
15. Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos.
Missikpode C; Kramer H; Cotler SJ; Durazo-Arvizu R; Lash JP; Kallwitz E; Cai J; Kuniholm MH; Rosas SE; Ricardo AC; Talavera GA; Raij L; Pirzada A; Daviglus ML
BMC Nephrol; 2021 Sep; 22(1):302. PubMed ID: 34493216
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
[TBL] [Abstract][Full Text] [Related]
17. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
18. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
19. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
[TBL] [Abstract][Full Text] [Related]
20. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study.
Doi Y; Kubo M; Yonemoto K; Ninomiya T; Iwase M; Tanizaki Y; Shikata K; Iida M; Kiyohara Y
Obesity (Silver Spring); 2007 Jul; 15(7):1841-50. PubMed ID: 17636103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
